HX OPTICAL LIMITED
Company number 15220865 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
HX OPTICAL LIMITED - Analysis Report
Company Number: 15220865
Analysis Date: 2025-07-29 13:06 UTC
Credit Opinion: CONDITIONAL APPROVAL
HX Optical Limited is a newly incorporated micro-entity (incorporated October 2023) with minimal financial history. The latest accounts (year ending October 2024) show very limited net assets (£131) and a small working capital deficit (£149 negative net current assets). This indicates a very tight liquidity position and minimal financial buffer. However, there are no overdue filings or signs of distress. Given the company's infancy and micro scale, credit approval should be conditional on close monitoring and possibly supported by personal guarantees or additional collateral if extending credit facilities.Financial Strength:
The balance sheet reveals extremely limited fixed assets (£280) and current assets (£5,671) almost matched by current liabilities (£5,820). Net assets stand at £131, representing nominal equity capital contributed by the sole shareholder who holds 75-100% of shares and voting rights. This minimal equity base and negligible asset coverage constrain the company’s financial strength and resilience. The micro classification limits filing requirements but restricts insight into profitability and cash generation.Cash Flow Assessment:
Current liabilities slightly exceed current assets, resulting in a small working capital deficit (-£149). This suggests potential liquidity strain, though at this scale, the absolute values are low. The company has one employee and minimal operations reported. Without detailed profit and loss or cash flow statements, it is difficult to fully assess operational cash flow or ability to service debt. The company’s capacity to generate positive cash flow and maintain liquidity must be closely evaluated, especially since it is very early in its trading lifecycle.Monitoring Points:
- Timely filing of future accounts and confirmation statements to avoid regulatory penalties.
- Improvements in net assets and working capital position indicating stronger financial footing.
- Cash flow trends and profit generation as trading matures.
- Changes in director or shareholder structure that might impact governance or control.
- Any growth in fixed assets or current assets supporting operational expansion.
- External market conditions affecting the "Other human health activities" sector where the company operates.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.